STAAR Surgical Company (STAA)
Solvency ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial leverage ratio | 1.28 | 1.26 | 1.25 | 1.25 | 1.27 | 1.25 | 1.25 | 1.24 | 1.25 | 1.23 | 1.26 | 1.27 | 1.34 | 1.30 | 1.25 | 1.24 | 1.31 | 1.26 | 1.25 | 1.25 |
For STAAR Surgical Company, the solvency ratios indicate a strong financial position in terms of its debt obligations. The Debt-to-assets ratio, Debt-to-capital ratio, and Debt-to-equity ratio have consistently remained at 0.00 from March 2020 to December 2024. This suggests that the company has not relied on debt to finance its assets, capital, or operations during this period.
The Financial leverage ratio, which measures the proportion of debt in the company's capital structure, has shown slight fluctuations but has generally remained within a reasonable range from 1.23 to 1.34. A ratio around 1 indicates a balanced mix of debt and equity, which can be considered healthy for the company's solvency.
Overall, based on the solvency ratios provided, STAAR Surgical Company appears to have a low level of debt relative to its assets and capital, demonstrating a conservative approach to managing its financial obligations and a strong financial position to meet its long-term commitments.
Coverage ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest coverage | — | 14.11 | 13.69 | 11.06 | 6.61 | 4.49 | 5.61 | 7.63 | 17.52 | 51.40 | 572.13 | 1,015.57 | 866.66 | 834.25 | 1,934.14 | 530.14 | 27.78 | 11.37 | 4.80 | 8.82 |
The interest coverage ratio measures a company's ability to meet its interest payments on outstanding debt. A higher interest coverage ratio indicates that a company is more capable of servicing its interest obligations.
Analyzing the interest coverage data of STAAR Surgical Company over the reported periods, we observe fluctuations in the ratio. The interest coverage ratio was 8.82 as of March 31, 2020, indicating that the company's operating income was 8.82 times its interest expense for that period.
The ratio then decreased to 4.80 as of June 30, 2020, suggesting a temporary decrease in the company's ability to cover interest payments. However, in the following quarters, the interest coverage ratio improved significantly, reaching 27.78 by December 31, 2020.
The trend continued to show impressive improvement, with interest coverage ratios soaring to 530.14 as of March 31, 2021, and further escalating to 1,934.14 by June 30, 2021. This sharp increase indicates a substantial increase in the company's operating income relative to its interest expenses during that period.
Subsequently, the interest coverage ratio declined but remained at relatively robust levels, ranging from 51.40 to 866.66 up to December 31, 2021. Since the end of 2021, the interest coverage ratio has witnessed further fluctuations, ranging from 5.61 to 14.11 until December 31, 2024.
Overall, the fluctuating trend in STAAR Surgical Company's interest coverage ratio reflects changes in its operating income relative to its interest expenses over the years, with periods of both strength and potential challenges in meeting interest obligations. Investors and lenders may monitor these fluctuations closely to assess the company's financial health and debt repayment capacity.